0000950170-23-052932.txt : 20231011 0000950170-23-052932.hdr.sgml : 20231011 20231011170029 ACCESSION NUMBER: 0000950170-23-052932 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230915 FILED AS OF DATE: 20231011 DATE AS OF CHANGE: 20231011 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saunders Ninfa CENTRAL INDEX KEY: 0001815499 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 231321240 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 ownership.xml 4 X0508 4 2023-09-15 0001492674 T2 Biosystems, Inc. TTOO 0001815499 Saunders Ninfa 101 HARTWELL AVENUE LEXINGTON MA 02421 true false false false false Common Stock 2023-09-15 4 M false 2300 A 7322 D Restricted Stock Units 2023-09-15 4 M false 2300 0.00 D Common Stock 2300 0 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On October 11, 2022, the reporting person was granted 2,300 restricted stock units that vested on the earlier of (i) October 11, 2023, and (ii) the date of the next annual meeting of stockholders. /s/ John Sprague, Attorney-in-Fact 2023-10-11